BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21153909)

  • 1. Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.
    Li G; Wei Q; Wang Y; Du X; Zhao Y; Jiang X
    Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):575-80. PubMed ID: 21153909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Cai JC; Zhou HW; Zhang R; Chen GX
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
    Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS
    Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of a Ceftazidime-Avibactam-Resistant
    Castanheira M; Arends SJR; Davis AP; Woosley LN; Bhalodi AA; MacVane SH
    mSphere; 2018 Sep; 3(5):. PubMed ID: 30258039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.
    Rasheed JK; Biddle JW; Anderson KF; Washer L; Chenoweth C; Perrin J; Newton DW; Patel JB
    J Clin Microbiol; 2008 Jun; 46(6):2066-9. PubMed ID: 18385437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of WGS data for investigation of a long-term NDM-1-producing Citrobacter freundii outbreak and secondary in vivo spread of blaNDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
    Hammerum AM; Hansen F; Nielsen HL; Jakobsen L; Stegger M; Andersen PS; Jensen P; Nielsen TK; Hansen LH; Hasman H; Fuglsang-Damgaard D
    J Antimicrob Chemother; 2016 Nov; 71(11):3117-3124. PubMed ID: 27494919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression.
    Zhang R; Yang L; Cai JC; Zhou HW; Chen GX
    J Med Microbiol; 2008 Mar; 57(Pt 3):332-337. PubMed ID: 18287296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of NDM-1-producing Escherichia coli and Citrobacter freundii in the same patient.
    Zhu B; Ying C; Xu H; Ying J
    J Glob Antimicrob Resist; 2018 Dec; 15():79-81. PubMed ID: 29727717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulation of
    Venditti C; Fortini D; Villa L; Vulcano A; D'Arezzo S; Capone A; Petrosillo N; Nisii C; Carattoli A; Di Caro A
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
    Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y
    Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of a novel KPC-2-encoding MDR plasmid and an NDM-1-encoding pNDM-HN380-like plasmid in a clinical isolate of Citrobacter freundii.
    Feng J; Qiu Y; Yin Z; Chen W; Yang H; Yang W; Wang J; Gao Y; Zhou D
    J Antimicrob Chemother; 2015 Nov; 70(11):2987-91. PubMed ID: 26260129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital.
    Luo Y; Yang J; Ye L; Guo L; Zhao Q; Chen R; Chen Y; Han X; Zhao J; Tian S; Han L
    Microb Drug Resist; 2014 Aug; 20(4):264-9. PubMed ID: 24433026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.
    Yigit H; Queenan AM; Rasheed JK; Biddle JW; Domenech-Sanchez A; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3881-9. PubMed ID: 14638498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.
    Mavroidi A; Miriagou V; Malli E; Stefos A; Dalekos GN; Tzouvelekis LS; Petinaki E
    Int J Antimicrob Agents; 2012 Mar; 39(3):247-50. PubMed ID: 22226650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
    Sekiguchi J; Morita K; Kitao T; Watanabe N; Okazaki M; Miyoshi-Akiyama T; Kanamori M; Kirikae T
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4194-7. PubMed ID: 18765691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lateral dissemination and inter-patient transmission of blaKPC-3: role of a conjugative plasmid in spreading carbapenem resistance.
    Tijet N; Muller MP; Matukas LM; Khan A; Patel SN; Melano RG
    J Antimicrob Chemother; 2016 Feb; 71(2):344-7. PubMed ID: 26518052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
    Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in Canada.
    Abdalhamid B; Pitout JD; Moland ES; Hanson ND
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4435-7. PubMed ID: 15504875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterobacteriaceae producing the KPC-2 carbapenemase from hospital sewage.
    Zhang X; Lü X; Zong Z
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):204-6. PubMed ID: 22463869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.